EX-2.1
from 8-K
129 pages
Agreement and Plan of Merger by and Among: Obsidian Therapeutics, Inc.; Galera Therapeutics, Inc.; Gazelle Parent, Inc.; Onyx Mergersub, Inc.; and Gazelle Merger Subsidiary, Inc.; Dated as of April 14, 2026
12/34/56
EX-2.1
from 8-K
88 pages
Agreement and Plan of Merger Among: Galera Therapeutics, Inc., a Delaware Corporation; Grape Merger Sub I, Inc., a Delaware Corporation; Grape Merger Sub II, LLC, a Delaware Limited Liability Company; and Nova Pharmaceuticals, Inc., a Delaware Corporation Dated as of December 30, 2024
12/34/56
